Clinical trials
Phase 2 Urologic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 4 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Allena Pharmaceuticals | 3 |
| Astellas Pharma Europe B.V. | 2 |
| argenx | 2 |
| AbbVie | 1 |
| Ain Shams University | 1 |
| Alnylam Pharmaceuticals | 1 |
| Goldfinch Bio, Inc. | 1 |
| HI-Bio, A Biogen Company | 1 |
| Jade Biosciences, Inc. | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urologic Diseases | 23 |
| Kidney Diseases | 14 |
| Glomerulonephritis | 5 |
| Urinary Bladder Diseases | 5 |
| Glomerulonephritis, IGA | 4 |
| Hyperoxaluria | 4 |
| Diabetes Complications | 3 |
| Diabetes Mellitus | 3 |
| Diabetic Nephropathies | 3 |
| Endocrine System Diseases | 3 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.